Thu, May 13, 2021
Wed, May 12, 2021
Tue, May 11, 2021

Tejas Savant Maintained (BDSX) at Buy with Decreased Target to $23 on, May 12th, 2021

Tejas Savant of Morgan Stanley, Maintained "Biodesix, Inc." (BDSX) at Buy with Decreased Target from $25 to $23 on, May 12th, 2021.

Tejas has made no other calls on BDSX in the last 4 months.



There is 1 other peer that has a rating on BDSX. Out of the 1 peers that are also analyzing BDSX, 0 agree with Tejas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tejas


  • Max Masucci of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $31 on, Tuesday, February 2nd, 2021